Pieris Pharmaceuticals PIRS reported its Q4 earnings results on Tuesday, March 1, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Pieris Pharmaceuticals beat estimated earnings by 56.67%, reporting an EPS of $-0.13 versus an estimate of $-0.3.
Revenue was up $6.57 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.0 which was followed by a 1.47% drop in the share price the next day.
Here's a look at Pieris Pharmaceuticals's past performance:
Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
---|---|---|---|---|
EPS Estimate | -0.24 | -0.26 | -0.17 | -0.24 |
EPS Actual | -0.24 | -0.25 | -0.07 | -0.26 |
Revenue Estimate | 5.32M | 2.07M | 6.47M | 3.82M |
Revenue Actual | 4.06M | 3.29M | 15.63M | 1.88M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.